A detailed history of Busey Wealth Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Busey Wealth Management holds 8,673 shares of EW stock, worth $642,842. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,673
Previous 8,838 1.87%
Holding current value
$642,842
Previous $816,000 29.9%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$59.7 - $93.78 $9,850 - $15,473
-165 Reduced 1.87%
8,673 $572,000
Q2 2024

Jul 23, 2024

BUY
$84.3 - $94.31 $13,909 - $15,561
165 Added 1.9%
8,838 $816,000
Q3 2023

Oct 23, 2023

SELL
$69.28 - $93.38 $4,087 - $5,509
-59 Reduced 0.68%
8,673 $600,000
Q2 2023

Jul 21, 2023

SELL
$81.41 - $94.33 $125,452 - $145,362
-1,541 Reduced 15.0%
8,732 $823,000
Q1 2023

Apr 25, 2023

SELL
$74.26 - $84.51 $22,278 - $25,353
-300 Reduced 2.84%
10,273 $849,000
Q2 2022

Aug 01, 2022

SELL
$86.5 - $128.27 $6,747 - $10,005
-78 Reduced 0.73%
10,573 $1.01 Million
Q4 2021

Jan 25, 2022

BUY
$106.37 - $130.68 $318,471 - $391,255
2,994 Added 39.1%
10,651 $1.38 Million
Q3 2021

Oct 29, 2021

BUY
$102.91 - $122.75 $497,364 - $593,250
4,833 Added 171.14%
7,657 $866,000
Q1 2021

Apr 20, 2021

BUY
$78.68 - $90.67 $4,799 - $5,530
61 Added 2.21%
2,824 $236,000
Q3 2020

Oct 16, 2020

BUY
$67.19 - $87.44 $185,645 - $241,596
2,763 New
2,763 $221,000
Q1 2020

Apr 17, 2020

SELL
$52.41 - $81.0 $48,269 - $74,601
-921 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $56,687 - $69,471
921 New
921 $203,000
Q4 2018

Feb 06, 2019

SELL
$46.41 - $56.94 $72,585 - $89,054
-1,564 Closed
0 $0
Q3 2018

Oct 12, 2018

BUY
$45.7 - $58.03 $71,474 - $90,758
1,564 New
1,564 $272,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Busey Wealth Management Portfolio

Follow Busey Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.